JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 990 JPY -0.37% Market Closed
Market Cap: 261B JPY

JMDC Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

JMDC Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
JMDC Inc
TSE:4483
Cash & Cash Equivalents
ÂĄ35.9B
CAGR 3-Years
-5%
CAGR 5-Years
40%
CAGR 10-Years
N/A
M3 Inc
TSE:2413
Cash & Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EM Systems Co Ltd
TSE:4820
Cash & Cash Equivalents
ÂĄ10.7B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
10%
S
Software Service Inc
TSE:3733
Cash & Cash Equivalents
ÂĄ16.3B
CAGR 3-Years
48%
CAGR 5-Years
20%
CAGR 10-Years
24%
Medley Inc
TSE:4480
Cash & Cash Equivalents
ÂĄ19B
CAGR 3-Years
10%
CAGR 5-Years
34%
CAGR 10-Years
N/A
CareNet Inc
TSE:2150
Cash & Cash Equivalents
ÂĄ7.3B
CAGR 3-Years
-2%
CAGR 5-Years
23%
CAGR 10-Years
22%
No Stocks Found

JMDC Inc
Glance View

Market Cap
261B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
4 182.4 JPY
Undervaluation 5%
Intrinsic Value
Price

See Also

What is JMDC Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
35.9B JPY

Based on the financial report for Sep 30, 2025, JMDC Inc's Cash & Cash Equivalents amounts to 35.9B JPY.

What is JMDC Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
40%

Over the last year, the Cash & Cash Equivalents growth was 31%. The average annual Cash & Cash Equivalents growth rates for JMDC Inc have been -5% over the past three years , 40% over the past five years .

Back to Top